Herb Cross - Net Worth and Insider Trading

Herb Cross Net Worth

The estimated net worth of Herb Cross is at least $6,189 dollars as of 2024-04-25. Herb Cross is the CFO of Atreca Inc and owns about 72,817 shares of Atreca Inc (BCEL) stock worth over $6,189. Details can be seen in Herb Cross's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Herb Cross has not made any transactions after 2023-08-02 and currently still holds the listed stock(s).

Transaction Summary of Herb Cross

Herb Cross Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Herb Cross owns 8 companies in total, including Atreca Inc (BCEL) , ARMO BioSciences Inc (ARMO) , and Humanigen Inc (HGENQ) among others .

Click here to see the complete history of Herb Cross’s form 4 insider trades.

Insider Ownership Summary of Herb Cross

Ticker	Comapny	Transaction Date	Type of Owner
BCEL	Atreca Inc	2023-08-02	Chief Financial Officer
ARMO	ARMO BioSciences Inc	2018-06-22	Chief Financial Officer
HGENQ	Humanigen Inc	2013-10-22	Chief Financial Officer
AFFY	Affymax Inc	2013-01-30	Chief Financial Officer
PDLI	PDL BioPharma Inc	2008-09-15	Corp Controller/Prin Acctg Off
APGN	Apexigen Inc	2022-07-29	director
BCACU	Brookline Capital Acquisition Corp	2022-07-29	director
JSPR	Jasper Therapeutics Inc	2023-09-22	Chief Financial Officer

Herb Cross Latest Holdings Summary

Herb Cross currently owns a total of 1 stock. Herb Cross owns 72,817 shares of Atreca Inc (BCEL) as of August 2, 2023, with a value of $6,189.

Latest Holdings of Herb Cross

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BCEL	Atreca Inc	2023-08-02	72,817	0.09	6,189

Holding Weightings of Herb Cross

Herb Cross Form 4 Trading Tracker

According to the SEC Form 4 filings, Herb Cross has made a total of 2 transactions in Atreca Inc (BCEL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Atreca Inc is the sale of 5,487 shares on August 2, 2023, which brought Herb Cross around $5,213.

Insider Trading History of Herb Cross

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Herb Cross Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Herb Cross Ownership Network

Ownership Network List of Herb Cross

No Data

Ownership Network Relation of Herb Cross

Herb Cross Owned Company Details

What does Atreca Inc do?

Who are the key executives at Atreca Inc?

Herb Cross is the Chief Financial Officer of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .

Atreca Inc (BCEL) Insider Trades Summary

Over the past 18 months, Herb Cross made 1 insider transaction in Atreca Inc (BCEL) with a net sale of 5,487. Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 20,788 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 20,788 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Atreca Inc Insider Transactions

No Available Data

What does ARMO BioSciences Inc do?

Who are the key executives at ARMO BioSciences Inc?

Herb Cross is the Chief Financial Officer of ARMO BioSciences Inc. Other key executives at ARMO BioSciences Inc include director & 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp V Llc , and 10 percent owner Orbimed Capital Gp Iv Llc .

ARMO BioSciences Inc (ARMO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARMO BioSciences Inc (ARMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARMO BioSciences Inc (ARMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARMO BioSciences Inc (ARMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARMO BioSciences Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Herb Cross is the Chief Financial Officer of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, Herb Cross made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Affymax Inc do?

Who are the key executives at Affymax Inc?

Herb Cross is the Chief Financial Officer of Affymax Inc. Other key executives at Affymax Inc include Chief Financial Officer Mark G Thompson , Chief Commercial Officer Jeffrey H Knapp , and Chief Medical Officer Anne-marie Duliege .

Affymax Inc (AFFY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymax Inc Insider Transactions

No Available Data

What does PDL BioPharma Inc do?

Who are the key executives at PDL BioPharma Inc?

Herb Cross is the Corp Controller/Prin Acctg Off of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP & Gen. Counsel & Secretary Christopher Lewis Stone , and VP Finance & CAO and Acting CFO Edward Imbrogno .

PDL BioPharma Inc (PDLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

PDL BioPharma Inc Insider Transactions

No Available Data

What does Apexigen Inc do?

Who are the key executives at Apexigen Inc?

Herb Cross is the director of Apexigen Inc. Other key executives at Apexigen Inc include Chief Operating Officer Francis Willard Sarena , Chief Medical Officer Frank J. Hsu , and Chief Financial Officer William E. Duke .

Apexigen Inc (APGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Apexigen Inc (APGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apexigen Inc (APGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Apexigen Inc (APGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apexigen Inc Insider Transactions

No Available Data

What does Brookline Capital Acquisition Corp do?

Who are the key executives at Brookline Capital Acquisition Corp?

Herb Cross is the director of Brookline Capital Acquisition Corp. Other key executives at Brookline Capital Acquisition Corp include Chief Operating Officer Francis Willard Sarena , Chief Medical Officer Frank J. Hsu , and Chief Financial Officer William E. Duke .

Brookline Capital Acquisition Corp (BCACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Brookline Capital Acquisition Corp (BCACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Brookline Capital Acquisition Corp (BCACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Brookline Capital Acquisition Corp (BCACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Brookline Capital Acquisition Corp Insider Transactions

No Available Data

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Herb Cross is the Chief Financial Officer of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Herb Cross made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net purchase of 50,000 shares made by Thomas G Wiggans , a net purchase of 3,323,333 shares made by Carlyle Group Inc. , and a net sale of 16,465 shares made by William Lis .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 540,000 shares, with a net purchase of 539,100 shares. During the past 18 months, 12,554 shares of Jasper Therapeutics Inc (JSPR) were sold and 1,125,000 shares were bought by its insiders, resulting in a net purchase of 1,112,446 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jasper Therapeutics Inc Insider Transactions

No Available Data

Herb Cross Mailing Address

Above is the net worth, insider trading, and ownership report for Herb Cross. You might contact Herb Cross via mailing address: 3061 Zanker Rd, San Jose Ca 95134.

Discussions on Herb Cross

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.